BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3768667)

  • 21. Stimulation and inhibition of growth hormone secretion by interleukin-1 beta: the involvement of growth hormone-releasing hormone.
    Payne LC; Obal F; Opp MR; Krueger JM
    Neuroendocrinology; 1992 Jul; 56(1):118-23. PubMed ID: 1641070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concomitant increases in serum growth hormone and hypothalamic somatostatin in rats after injection of gamma-aminobutyric acid, aminooxyacetic acid, or gamma-hydroxybutyric acid.
    Takahara J; Yunoki S; Hosogi H; Yakushiji W; Kageyama J; Ofuji T
    Endocrinology; 1980 Jan; 106(1):343-7. PubMed ID: 7349964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of growth hormone and thyrotropin secretion by somatostatin systems in rat brain.
    Terry LC; Crowley WR
    Neuroendocrinology; 1986; 42(3):218-25. PubMed ID: 2869424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early increase in pulsatile growth hormone release after unilateral nephrectomy in adult rats.
    Haramati A; Lumpkin MD; Mulroney SE
    Am J Physiol; 1994 Apr; 266(4 Pt 2):F628-32. PubMed ID: 8184896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth hormone releasing hormone induced release of growth hormone in aging male rats: dependence on pharmacological manipulation and endogenous somatostatin release.
    Sonntag WE; Gough MA
    Neuroendocrinology; 1988 Jun; 47(6):482-8. PubMed ID: 2840597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of endogenous atrial natriuretic peptide in resting and stress-induced release of corticotropin, prolactin, growth hormone, and thyroid-stimulating hormone.
    Franci CR; Anselmo-Franci JA; McCann SM
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11391-5. PubMed ID: 1333608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma prolactin increase following electric stimulation of the amygdala in humans.
    Parra A; Velasco M; Cervantes C; Muñoz H; Cerbón MA; Velasco F
    Neuroendocrinology; 1980 Jul; 31(1):60-5. PubMed ID: 6771666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Connections of the hypothalamic paraventricular nucleus with the neurohypophysis, median eminence, amygdala, lateral septum and midbrain periaqueductal gray: an electrophysiological study in the rat.
    Pittman QJ; Blume HW; Renaud LP
    Brain Res; 1981 Jun; 215(1-2):15-28. PubMed ID: 7260585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for a physiological role of hypothalamic gastrin-releasing peptide to suppress growth hormone and prolactin release in the rat.
    Kentroti S; Dees WL; McCann SM
    Proc Natl Acad Sci U S A; 1988 Feb; 85(3):953-7. PubMed ID: 3422472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Connections of medial preoptic neurons with the median eminence and amygdala. An electrophysiological study in the rat.
    Layton BS; Lafontaine S; Renaud LP
    Neuroendocrinology; 1981; 33(4):235-40. PubMed ID: 7290340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cysteamine-induced enhancement of growth hormone-releasing factor (GRF) immunoreactivity in arcuate neurons: morphological evidence for putative somatostatin/GRF interactions within hypothalamus.
    Tannenbaum GS; McCarthy GF; Zeitler P; Beaudet A
    Endocrinology; 1990 Nov; 127(5):2551-60. PubMed ID: 1977581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical mapping of somatostatinergic systems in rat brain: effects of periventricular hypothalamic and medial basal amygdaloid lesions on somatostatin-like immunoreactivity in discrete brain nuclei.
    Crowley WR; Terry LC
    Brain Res; 1980 Nov; 200(2):283-91. PubMed ID: 6106526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long term elevations in plasma thyrotropin, but not growth hormone, concentrations associated with lesion-induced depletion of median eminence somatostatin.
    Urman S; Critchlow V
    Endocrinology; 1983 Feb; 112(2):659-64. PubMed ID: 6129135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of dexamethasone implanted in different brain areas on the morphine-induced PRL, GH and ACTH/corticosterone secretion.
    Kiem DT; Bartha L; Makara GB
    Brain Res; 1991 Nov; 563(1-2):107-13. PubMed ID: 1664769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of impaired growth hormone secretion in genetically obese Zucker rats: roles of growth hormone-releasing factor and somatostatin.
    Tannenbaum GS; Lapointe M; Gurd W; Finkelstein JA
    Endocrinology; 1990 Dec; 127(6):3087-95. PubMed ID: 1979030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition by gastrin-releasing peptide of growth hormone (GH) secretion induced by human pancreatic GH-releasing factor in rats.
    Kabayama Y; Kato Y; Shimatsu A; Ohta H; Yanaihara N; Imura H
    Endocrinology; 1984 Aug; 115(2):649-53. PubMed ID: 6146511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypothalamic somatostatin mediates the suppression of growth hormone secretion by centrally administered thyrotropin-releasing hormone in conscious rats.
    Katakami H; Arimura A; Frohman LA
    Endocrinology; 1985 Sep; 117(3):1139-44. PubMed ID: 2862016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effect of hypothalamic medial preoptic area somatostatin on growth hormone-releasing factor in the rat.
    Katakami H; Downs TR; Frohman LA
    Endocrinology; 1988 Aug; 123(2):1103-9. PubMed ID: 2899498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of various traumatic stresses on growth hormone release in pentobarbital anesthetized rats.
    Takahashi K
    Neuroendocrinology; 1978; 26(1):1-7. PubMed ID: 673141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of hypothalamic control of growth hormone secretion in the rat.
    Khorram O; DePalatis LR; McCann SM
    Endocrinology; 1983 Aug; 113(2):720-8. PubMed ID: 6135598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.